Picture of IRulya Therapeutics logo

IRLA — IRulya Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Quince Therapeutics Announces Pricing Of Up To $22 Mln Private Placement Of Securities

June 12 (Reuters) - Quince Therapeutics Inc QNCX.O:

QUINCE THERAPEUTICS ANNOUNCES PRICING OF UP TO $22 MILLION PRIVATE PLACEMENT OF SECURITIES

QUINCE THERAPEUTICS INC - FINANCING TO PROVIDE $11.5 MILLION UPFRONT, $10.4 MILLION FROM WARRANTS

QUINCE THERAPEUTICS INC - PROCEEDS TO FUND PHASE 3 NEAT TRIAL AND CORPORATE PURPOSES

QUINCE THERAPEUTICS INC - PROCEEDS EXPECTED TO FUND OPERATIONS INTO SECOND QUARTER 2026

Source text: ID:nBw4Lyg3Wa

Further company coverage: QNCX.O

 (((( Reuters.briefs@thomsonreuters.com ;));))

Recent news on IRulya Therapeutics

See all news